PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Common heart failure drugs could benefit more patients

2012-11-28
(Press-News.org) Heart failure affects 3 per cent of the overall population, and exists in two forms: reduced ability to contract the heart and reduced ability to relax the heart. The former affects younger patients, mostly men, and is treatable. The latter, called HFPEF (heart failure with preserved ejection fraction), affects older patients and women, and until now there has not been any treatment available against the disease.

In the present study, a team comprising researchers at Karolinska Institutet, Linköping University, Stockholm South General Hospital and Karolinska University Hospital analysed data from about 40,000 patients from the large Swedish Heart Failure Registry. The result showed that patients with HFPEF who were treated with ACE-inhibitors or angiotensin receptor blockers – which are commonly used drugs to lower the blood pressure – had better survival than un-treated patients. The difference persisted after adjustment for a large number of other factors, such as patient age, general health and other factors, and the final decrease in mortality was 10 per cent.

In heart failure, stress hormones are secreted that are damaging to the heart in the long term, and ACE-inhibitors and angiotensin receptor blockers both work to stop the adverse effects of these hormones. In previous randomized studies, the drugs have not proven effective against HFPEF, but the researchers behind the current finding suggest that earlier studies may have been too small to detect a benefit. At the same time they point out that because their study was not randomized, further research is needed to confirm these novel results.

"However, the large number of patients and the extensive statistical adjustments suggest a strong likelihood of a benefit from ACE-inhibitors and angiotensin receptor blockers", says Docent Lars Lund of Karolinska Institutet, who led the study. "One might also add that these drugs are in comparison not that expensive."

INFORMATION:

The work was financed by the Swedish Heart Lung Foundation, the Stockholm County Council and the Swedish Association of Local Authorities and Regions.

Publication: 'Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction – a prospective propensity score-matched cohort study', Lars H Lund, Lina Benson, Ulf Dahlström och Magnus Edner, Journal of the American Medical Association, JAMA, 28 November 2012, Vol 308, No 20.

Journal website: http://jama.jamanetwork.com/journal.aspx

About the Swedish Heart Failure Registry: http://www.ucr.uu.se/rikssvikt-en/

For further information, please contact:
Lars Lund, PhD, Associate Professor, Assistant Consultant
Department of Medicine, Solna - Karolinska Institutet
Mobile: +46 (0)70-441 56 87
Email: Lars.Lund@ki.se or Lars.Lund@alumni.duke.edu

Contact the Press Office and download photo: http://ki.se/pressroom

Karolinska Institutet is one of the world's leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. More on http://ki.se/english

END



ELSE PRESS RELEASES FROM THIS DATE:

Digoxin increases deaths in patients with atrial fibrillation

2012-11-28
Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase in deaths in patients with atrial fibrillation (AF), according to results from a study published online today (Wednesday) in the European Heart Journal [1]. Digoxin is extracted from the foxglove plant (digitalis) and it helps the heart beat more strongly and with a more regular rhythm. It is commonly used in AF patients, and also in patients with heart failure. However, it can be problematic to use successfully as there is a narrow dose range at ...

Thyroid problems linked to irregular heart rhythm

2012-11-28
People with an overactive thyroid gland (hyperthyroidism) carry a greater risk of developing irregular heart rhythm (known as atrial fibrillation) than those with normal thyroid function, finds a study published on bmj.com today. As such, the researchers suggest there should be an increased focus on atrial fibrillation in patients with raised thyroid function. Hyperthyroidism occurs when the thyroid gland makes too much thyroxine (thyroid hormone), causing many of the body's functions to speed up. About 1 in 100 women and 1 in 1,000 men develop hyperthyroidism at some ...

One child mothers with pre-eclampsia at higher risk of heart problems

2012-11-28
Women who develop pre-eclampsia during their first pregnancy (known as preterm pre-eclampsia) - and who don't go on to have any more children – are at greater risk of dying from heart disease in later life than women who have subsequent children, finds a study published on bmj.com today. Women who develop the condition only in the final weeks of pregnancy (known as term pre-eclampsia) are at less risk. This high risk to one child mothers has not been previously reported and suggests that these women need special monitoring, especially if their pre-eclampsia was preterm. ...

Projected sea-level rise may be underestimated

2012-11-28
That sea level is rising faster than expected could mean that the Intergovernmental Panel on Climate Change's (IPCC) sea-level rise projections for the future may be biased low as well, their results suggest. Sea-level rise potentially affects millions of people all around the world in coastal areas as well as megacities like Tokyo. "Global temperature continues to rise at the rate that was projected in the last two IPCC Reports. This shows again that global warming has not slowed down or is lagging behind the projections," Rahmstorf says. Five global land and ocean ...

Malaria study suggests drugs should target female parasites

2012-11-28
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease. Research into malaria parasites – which exist in male and female forms, and mate to spread the disease – suggests that treatments would be more likely to succeed if designed to target female forms of the parasite. Scientists found that male parasites can adapt to new surroundings faster than the females. When malaria infects the bloodstream after a mosquito bite, the male parasites are better able to react quickly to repeated attacks by the immune ...

For some feathered dinosaurs, bigger not necessarily better

For some feathered dinosaurs, bigger not necessarily better
2012-11-28
Every kid knows that giant carnivores like Tyrannosaurus rex dominated the Cretaceous period, but they weren't the only big guys in town. Giant plant-eating theropods – close relatives of both T. rex and today's birds – also lived and thrived alongside their meat-eating cousins. Now researchers have started looking at why dinosaurs that abandoned meat in favor of vegetarian diets got so big, and their results may call conventional wisdom about plant-eaters and body size into question. Scientists have theorized that bigger was better when it came to plant eaters, because ...

Compound found in rosemary protects against macular degeneration in laboratory model

Compound found in rosemary protects against macular degeneration in laboratory model
2012-11-28
LA JOLLA, Calif., November 27, 2012 – Herbs widely used throughout history in Asian and early European cultures have received renewed attention by Western medicine in recent years. Scientists are now isolating the active compounds in many medicinal herbs and documenting their antioxidant and anti-inflammatory activities. In a study published in the journal Investigative Ophthalmology & Visual Science, Stuart A. Lipton, M.D., Ph.D. and colleagues at Sanford-Burnham Medical Research Institute (Sanford-Burnham) report that carnosic acid, a component of the herb rosemary, promotes ...

Increasing drought stress challenges vulnerable hydraulic system of plants, GW professor finds

2012-11-28
WASHINGTON - The hydraulic system of trees is so finely-tuned that predicted increases in drought due to climate change may lead to catastrophic failure in many species. A recent paper co-authored by George Washington University Assistant Professor of Biological Sciences Amy Zanne finds that those systems in plants around the globe are operating at the top of their safety threshold, making forest ecosystems vulnerable to increasing environmental stress. In the current issue of the journal Nature, Dr. Zanne and lead authors from the University of Western Sydney in Australia ...

GSA Today: Human transformation of land threatens future sustainability?

GSA Today: Human transformation of land threatens future sustainability?
2012-11-28
Boulder, Colorado, USA - Social and physical scientists have long been concerned about the effects of humans on Earth's surface -- in part through deforestation, encroachment of urban areas onto traditionally agricultural lands, and erosion of soils -- and the implications these changes have on Earth's ability to provide for an ever-growing population. The December 2012 GSA Today science article presents examples of land transformation by humans and documents some of the effects of these changes. Researchers Roger Hooke of the University of Maine, USA, and José F. Martín-Duque ...

Resolving conflicts over end-of-life care: Mayo experts offer tips

2012-11-28
ROCHESTER, Minn. -- It's one of the toughest questions patients and their loved ones can discuss with physicians: When is further medical treatment futile? The conversation can become even more difficult if patients or their families disagree with health care providers' recommendations on end-of-life care. Early, clear communication between patients and their care teams, choosing objective surrogates to represent patients and involving third parties such as ethics committees can help avoid or resolve conflicts, Mayo Clinic experts Christopher Burkle, M.D., J.D., and Jeffre ...

LAST 30 PRESS RELEASES:

New guidelines for managing blood cancers in pregnancy

New study suggests RNA present on surfaces of leaves may shape microbial communities

U.S. suffers from low social mobility. Is sprawl partly to blame?

Research spotlight: Improving predictions about brain cancer outcomes with the right imaging criteria

New UVA professor’s research may boost next-generation space rockets

Multilingualism improves crucial cognitive functions in autistic children

The carbon in our bodies probably left the galaxy and came back on cosmic ‘conveyer belt’

Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target

NASA’s LEXI will provide X-ray vision of Earth’s magnetosphere

A successful catalyst design for advanced zinc-iodine batteries

AMS Science Preview: Tall hurricanes, snow and wildfire

Study finds 25% of youth experienced homelessness in Denver in 2021, significantly higher than known counts

Integrated spin-wave quantum memory

Brain study challenges long-held views about Parkinson's movement disorders

Mental disorders among offspring prenatally exposed to systemic glucocorticoids

Trends in screening for social risk in physician practices

Exposure to school racial segregation and late-life cognitive outcomes

AI system helps doctors identify patients at risk for suicide

Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases

Study reveals oldest-known evolutionary “arms race”

People find medical test results hard to understand, increasing overall worry

Mizzou researchers aim to reduce avoidable hospitalizations for nursing home residents with dementia

National Diabetes Prevention Program saves costs for enrollees

Research team to study critical aspects of Alzheimer’s and dementia healthcare delivery

Major breakthrough for ‘smart cell’ design

From CO2 to acetaldehyde: Towards greener industrial chemistry

Unlocking proteostasis: A new frontier in the fight against neurodegenerative diseases like Alzheimer's

New nanocrystal material a key step toward faster, more energy-efficient computing

One of the world’s largest social programs greatly reduced tuberculosis among the most vulnerable

Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

[Press-News.org] Common heart failure drugs could benefit more patients